Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Detection and Characterization of Verocytotoxin-Producing Escherichia coli by Automated 5′ Nuclease PCR Assay

Eva Møller Nielsen, Marianne Thorup Andersen
Eva Møller Nielsen
Danish Veterinary Institute, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: emn@ssi.dk
Marianne Thorup Andersen
Danish Veterinary Institute, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.41.7.2884-2893.2003
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

In recent years increased attention has been focused on infections caused by isolates of verocytotoxin-producing Escherichia coli (VTEC) serotypes other than O157. These non-O157 VTEC isolates are commonly present in food and food production animals. Easy detection, isolation, and characterization of non-O157 VTEC isolates are essential for improving our knowledge of these organisms. In the present study, we detected VTEC isolates in bovine fecal samples by a duplex 5′ nuclease PCR assay (real-time PCR) that targets vtx1 and vtx2. VTEC isolates were obtained by colony replication by use of hydrophobic-grid membrane filters and DNA probe hybridization. Furthermore, we have developed 5′ nuclease PCR assays for the detection of virulence factors typically present in VTEC isolates, including subtypes of three genes of the locus of enterocyte effacement (LEE) pathogenicity island. The 22 assays included assays for the detection of verocytotoxin genes (vtx1, vtx2), pO157-associated genes (ehxA, katP, espP, and etpD), a recently identified adhesin (saa), intimin (eae, all variants), seven subtypes of eae, four subtypes of tir, and three subtypes of espD. A number of reference strains (VTEC and enteropathogenic E. coli strains) and VTEC strains isolated from calves were tested to validate the PCR assays. The expected virulence profiles were detected for all reference strains. In addition, new information on the subtypes of LEE genes was obtained. For reference strains as well as bovine isolates, a consistent relationship between subtypes of the LEE genes was found, so that a total of seven different combinations of these were recognized (corresponding to the seven subtypes of eae). Isolates with 15 different serogroup-virulence profiles were isolated from 16 calves. Among these, 53% harbored LEE and 73% harbored factors carried by the large virulence plasmid. One LEE-negative isolate had the gene for the adhesin Saa. The most common virulence profile among the bovine isolates was vtx1, eae-ζ, tir-α, ehxA, and espP. This panel of assays offers an easy method for the extensive characterization of VTEC isolates.

A large number of different serotypes of verocytotoxin (VT)-producing Escherichia coli (VTEC)—also known as Shiga toxin-producing E. coli—have been identified as causative agents of hemorrhagic colitis (HC) and hemolytic-uremic syndrome(HUS) (http://www.sciencenet.com.au/vtectable.htm ). Themost well known VTEC serotype is E. coli O157:H7, which has been implicated in many large outbreaks of HC and HUS. However, VTEC strains of other serotypes have increasingly been implicated in sporadic cases and outbreaks of serious illness, e.g., serotypes O26, O111, O103, and O145 (51). VTEC strains known to be pathogenic for humans as well as VTEC strains with an unknown potential to cause HC and HUS are commonly isolated from healthy cattle. Among the most important sources of human infection are direct contact with cattle and other ruminants and contaminated bathing water, beef products, unpasteurized milk, vegetables, fruits, and drinking water (48).

The focus on E. coli O157 instead of other VTEC serotypes has been further enhanced by the ease of isolation of E. coli O157 due to fast and sensitive methods based on immunomagnetic capture and selective or indicative media. In contrast, the isolation of other VTEC serotypes from human patients and potential reservoirs and sources has been hampered by the lack of such methods to isolate all relevant VTEC strains. PCR detection of VT genes in fecal samples and foods has, however, been widely used (12, 34). However, if a bacterial isolate is wanted, e.g., for the important further analysis of its virulence profile, a subsequent step of isolation is needed. VTEC isolates are usually considerably outnumbered by other E. coli strains, especially in fecal samples from healthy carriers of VTEC, e.g., cattle. As no selective or indicative medium exists for strains of all VTEC serotypes, most approaches for the isolation of such strains are laborious, e.g., PCR screening of a large number of colonies, and have a low rate of success. However, colony replication by use of hydrophobic-grid membrane filters (HGMFs) and DNA probe hybridization has been used with success for the isolation of VTEC strains from animal fecal samples (9, 47).

The frequent presence of VTEC in cattle and other ruminants calls for further analysis of the pathogenic potential for humans of VTEC strains isolated from nonhuman sources. An increasing number of putative virulence genes of VTEC have been characterized. At present, the most relevant virulence factors are considered to be the VTs and variants of these, the pathogenicity island locus of enterocyte effacement (LEE), and factors situated on the large virulence plasmid of many VTEC strains. Production of VT is the single most important factor, which is considered essential for the development of HC and HUS (30). The two main toxins are VT1 and VT2; however, a number of VT2 variants exist, and these possess various biological effects (30). The LEE region of E. coli O157 strain EDL933 has 54 genes (38) and codes for proteins for intimate adhesion to the intestinal epithelium and the generation of the characteristic attaching-and-effacing lesions. LEE encodes a type III secretion system, the outer surface protein intimin (coded by eae), the translocated receptor Tir, and several secreted effector proteins (Esp) (11, 29, 38)

Most of the frequently isolated VTEC serotypes causing HC and HUS possess LEE, or at least eae, as tests for other genes in the region are usually not conducted. However, important exceptions exist; e.g., it was found that strains of VTEC O91 and O113 responsible for an HUS outbreak lacked the LEE region (36). Recent findings have shown that these LEE-negative strains have another adhesin, designated Saa, which is probably encoded on the large virulence plasmid (35). The large virulence plasmid of two E. coli O157 strains has been fully sequenced (7, 28); and a number of putative virulence factors have been identified on this plasmid, e.g., enterohemolysin (ehxA), katalase-peroxidase (katP) (5), a type II secretion system (etp) (42), and a serine protease (espP) (6).

VTEC strains isolated from cattle, food, and other animal sources have various virulence profiles; and to assess the potential virulence of VTEC isolates from these sources, it is important to be able to examine them for the presence of virulence genes. Furthermore, large biologically important variations have been identified in several of these virulence factors, especially VT2 and the LEE region. For example, differences in lengths, insertion sites, and gene sequences have been found for the LEE region (11, 37, 38, 53); and specific variants of intimin have been found to be related to VTEC strains pathogenic for humans, whereas other intimin variants have been found to be related to human or animal enteropathogenic E. coli (EPEC) strains (1, 33). It has recently been shown that the intimin variant influences the site of colonization; e.g., intimin-γ from E. coli O157 appears to restrict colonization to Peyer's patches of the human intestine (39).

PCR is widely used for the detection of virulence factors, and PCR techniques are generally known to be sensitive and specific methods. Gel electrophoresis is most widely used for detection of the amplified product. However, this method lacks specificity; and other post-PCR processing steps should be performed to ensure specific detection, e.g., probe hybridization or restriction fragment analysis, which is time-consuming and not conducive to rapid, high-throughput automated schemes. TaqMan 5′ nuclease assays allow automated PCR amplification, detection, and analysis. This approach uses dual labeled fluorogenic hybridization probes incorporated into PCR and exploits the 5′→3′ exonuclease activity of Taq DNA polymerase to hydrolyze these probes during the DNA polymerization step (18, 24). The probe is labeled with a reporter dye and a quencher dye, and for the intact probe, the quencher dye suppresses the fluorescent emission of the reporter dye because of the spatial proximity of the probe. If hybridization occurs, the probe is cleaved by the 5′ nuclease activity of the DNA polymerase during extension of the primer (24). This separates the reporter dye from the quencher dye and generates an increase in the fluorescence signal of the reporter dye. Repeated PCR cycles result in exponential amplification of the PCR product and a corresponding increase in fluorescence intensity. The development of reporter signals is monitored throughout the PCR by a fluorometer and eliminates the need for post-PCR sample handling. The 5′ nuclease assays have recently been used for the detection and characterization of pathogens, e.g., for the detection of Vibrio cholerae (27), identification of Salmonella (19), and detection of virulence factors in porcine E. coli strains (14); and recently, assays that detect up to four virulence factors of E. coli O157 and other VTEC strains have been reported (40, 43).

The objective of the present study was to develop a reliable method for the detection and isolation of all VTEC strains from animal feces and to develop an easy system for determination of the most important virulence factors in VTEC isolates. The panel of virulence factors in the detection system includes two vtx variants; eae, tir, and espD and variants of these (LEE region genes); saa; and four genes on plasmid pO157 (ehxA, katP, etD, and espP); this plasmid is present in many VTEC serotypes other than O157.

MATERIALS AND METHODS

Bacterial strains. E. coli reference strains were used as positive and negative controls for the panel of primers and probes used for the detection of virulence factors (Table 1). In addition, other well-characterized E. coli O157 strains were included (Table 2). Strains 493/89, TB154A, RDEC-1, and 90-1787 were kindly provided by Tom Whittam, The National Food Safety and Toxicology Center, Michigan State University. The other strains were from our in-house collection.

View this table:
  • View inline
  • View popup
TABLE 1.

Validation of the 5′ nuclease detection assays by testing positive and negative control strainsa

View this table:
  • View inline
  • View popup
TABLE 2.

Results of characterization of reference strains and other well-described strains

Preparation of DNA from pure cultures.Bacterial strains were grown (18 to 24 h at 37°C) on blood agar plates, and one loopful (approximately 10 μl) of bacterial culture was suspended in 200 μl of sterile distilled water and lysed at 100°C for 10 min.

Probe and primer design.Primer and probe sets were designed for detection of the following VTEC- and EPEC-related virulence factors: genes for the two main VT subtypes (vtx1 and vtx2); four plasmid-borne genes (ehlyA, katP, espP, and etpD); three genes of the LEE pathogenicity island (eae, tir, and espD), including variants of these; and the gene encoding the STEC autoagglutinating adhesin, Saa (saa). Primer Express Software (version 2.0; Applied Biosystems, Foster City, Calif.), together with the corresponding guidelines (User's Manuel; Applied Biosystems), was used to design the primers and probes for the TaqMan PCR. BLAST N database searches were done, and the primer and probe sequences were designed to be specific for a region that had no homology with other known regions of interest in the database and that covered all relevant strains in the database. The probes and primers, listed in Table 3, were synthesized by DNA Technology (Århus, Denmark). Specifically, the vtx2-specific assay included primers and probes specific for all vtx2 variants except vt2e, which is related to edema disease in pigs and which is rarely related to disease in humans.

View this table:
  • View inline
  • View popup
TABLE 3.

Probes and primers used for automated 5′ nuclease PCR assays

TaqMan PCR assays.The 5′ nuclease PCR assays were carried out in 20-μl volumes containing 2 μl of template lysate, 600 nM each primer, 200 nM each probe, and the TaqMan Universal Master Mix (Applied Biosystems). The Master Mix contained AmpErase uracil-N-glycosylase (UNG), deoxynucleoside triphosphates with dUTPs, 6-carboxy-S-rhodamine as an internal passive fluorogenic reference, and optimized buffer components. Multiplex as well as single-reaction assays were performed with these concentrations. To optimize the work routine and minimize waste of the Master Mix, batches of mix in 70 to 80 tubes with one or two factors (for nonmultiplex or multiplex PCR) were prepared and stored at −20°C. A few minutes before use the required numbers of tubes were taken from the freezer and template was added.

Thermal cycling consisted of initial steps at 50°C for 2 min, which is required for optimal AmpErase UNG enzyme activity, and 95°C for 10 min, to activate the AmpliTaq Gold DNA polymerase and to deactivate the AmpErase UNG enzyme. This was followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. An ABI Prism 7700 Sequence Detection System (Applied Biosystems) was used for amplification and fluorescence measurement.

Post-PCR analysis.The fluorescent intensity of each dye was measured with the ABI Prism 7700 Sequence Detection System at every temperature step and cycle during the reaction. Data acquisition and analysis were handled by Sequence Detector software (version 1.7; Applied Biosystems). Briefly, a normalized reporter value (Rn) was calculated by dividing the reporter dye intensity by the passive reference dye intensity; and the change in Rn (ΔRn), an indication of the magnitude of the signal generated by the PCR, was determined. The cycle threshold (Ct) value is the first cycle at which a statistically significant increase in ΔRn is detected and is based on an arbitrary threshold of the average standard deviation of ΔRn during the early cycles. The Ct value is inversely proportional to the amount of target DNA. Generally, samples with ΔRn values exceeding the threshold and a clear indication of probe cleavage (judged by the multicomponent analysis) were considered positive. However, when VT-specific assays were run with enriched fecal samples, a Ct value less than 30 was used as a selection criterion, as initial trials showed that VTEC strains could not be isolated from samples with higher Ct values.

Cattle fecal samples.Two dairy cattle farms were visited once during June 2001, and 20 calves ages 2 to 6 months were sampled from each farm. These farms had participated in a longitudinal VTEC O157 study during the preceding year and had been positive for VTEC O157 in the summer and autumn of 2000 but were negative in January 2001.

Detection of VT genes and isolation of VTEC from fecal samples.Screening for vtx-positive fecal samples was performed by enrichment followed by TaqMan PCR for vtx1 and vtx2 (multiplex PCR). Ten grams of feces was suspended in 90 ml of buffered peptone water, and the suspension was incubated overnight at 37°C. A 0.2-ml aliquot of enrichment culture supernatant was added to 0.8 ml of tryptic soy broth, and the mixture was centrifuged at 12,000 × g for 3 min. The pellet was resuspended in 0.2 ml of sterile distilled water and boiled for 10 min to lyse the cells. The suspension was centrifuged at 1,700 × g for 5 min, and the supernatant was used as the template. The TaqMan PCR assay was performed as described above by using probes and primers for the detection of both vtx1 and vtx2 in each reaction. The enrichment cultures showing a positive reaction in the PCR assay for vtx1 and/or vtx2 were used for isolation of VTEC by the HGMF replica method, as described by Cobbold and Desmarchelier (9). Briefly, 1 ml of a 10−5 dilution of the enrichment culture was mixed with 8 ml of saline, and the mixture was filtered through HGMFs with 1,600 separate cells (ISO-GRID membranes; pore size, 0.45 μm; Acumedia Manufacturers Inc., Baltimore, Md.) by using a spread filter (Filtaflex Ltd., Almonte, Ontario, Canada). The filters were placed on modified hemorrhagic colitis (mHC) agar (44) and incubated overnight at 37°C. One replica of the colonies on the HGMF was placed onto another HGMF with a replicator (Filtaflex Ltd). The replicate was used for hybridization after overnight incubation on mHC agar (Fig. 1). Colony hybridization was performed with the digoxigenin (DIG) wash and block buffer kit (Roche Diagnostics, Mannheim, Germany), according to the recommendations of the manufacturer. DIG-labeled DNA probes were made by use of the PCR DIG labeling kit (Roche Diagnostics) with primers MK1 and MK2 (22). The vtx genes of two E. coli O157 strains, EDL933 (vtx1 vtx2) and E32511 (vtx2), served as templates for the production of probes, and these were pooled and used for the detection of both vtx1 and vtx2.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

(Left) mHC agar plate with an HGMF placed on top showing the growth of approximately 230 E. coli colonies in the 40-by-40 grid of the HGMF. (Right) Replicate of the filter on the left after hybridization with DIG-labeled vtx-specific probes. Fourteen E. coli colonies were found to be vtx positive in this example.

Serotyping and VT subtyping of E. coli isolates.The O serogroups of the VTEC isolates were determined with antisera against E. coli antigens O1 to O175 as described previously (13). The variants of the vtx genes were determined by restriction fragment length polymorphism analysis of the vtx genes as described previously (31). This method is based on PCR detection of all vtx genes (25) followed by digestion with HincIII (3) and distinguishes between vtx1, vtx2, vtx2c (including vtx2d1 and vtx-OX3/b-031), vtx2d2, vtx2e, etc.

RESULTS

Detection of virulence factors by automated 5′ nuclease assay (TaqMan).Primer and probe combinations were designed for detection of a panel of virulence factors and variants of these relevant for VTEC and EPEC isolates: the two vtx genes, five plasmid-borne genes, and the three genes of the LEE pathogenicity island, including seven variants of eae, four variants of tir, and three variants of espD (Table 3). These primer and probe combinations were designed to detect all relevant sequences found in GenBank but not irrelevant genes. Primers and probes for variant vtx2e (related to edema disease in pigs) were not included in the vtx2-specific assay.

General primer and probe sets was designed to detect all known eae variants, and in addition, primer and probe sets were designed for the detection of seven eae variants. The nomenclature established previously was used (1, 33, 46), so that eae-β2 and eae-γ2 identified by Oswald et al. (33) are termed eae-δ and eae-θ, respectively, and variant eae-ζ is based on the eae sequences of O84 and O111:H9 (46). Due to the high level of variation, general primers and probes could not be designed for the other selected genes of the LEE region (tir and espD), but primers and probes for the detection of known variants of these were made (Table 3). The nomenclature for tir and espD follows the same principle as that for eae, as described by China et al. (8), but with the separation of tir-γ into two variants: tir-γ and tir-θ. As tir sequences are available from only a limited number of strains, primers and a probe could be designed for the detection of only four variants of tir, although it must be expected that there are more variants (the sequences of the tir genes from strains with eae-δ, eae-ε, and eae-ζ are not available). All E. coli tir sequences in GenBank should be detected by one of the four assays specific for tir variants (perfect match of primer and probe sequences). Primers and probes for the detection of three espD subtypes (subtypes α, β, and γ) were designed, and these detected all but one sequence in GenBank. Information on the strain with a different espD sequence is scarce (diffusely adherent EPEC O8:H−; GenBank accession no. Y17874 ; no other genes of this strain have been sequenced), and therefore, it is unknown how this variant relates to other LEE variants.

Each of the 22 detection assays was validated by testing positive and negative control strains (Table 1), which were selected on the basis of the presence or absence of the various factors by the use of other methods, as described in the literature. All TaqMan assays were found to give the expected results. Examples of the amplification plots for detection of saa, eae, and the eae subtypes are shown in Fig. 2.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

Examples of amplification plots from real-time PCRs for detection of saa, eae, and eae variants. The amplification plots for detection of eae and saa for the positive and negative control strains are shown. For the seven eae variants, the results for the positive control strains are shown.

The whole panel of detection assays was tested with a number of well-characterized E. coli strains (mainly VTEC and EPEC strains) to further validate the method and to obtain more complete virulence profiles for these strains (Table 2). All sorbitol-nonfermenting O157:H7 and O157:H− strains had the LEE profile eae-γ, tir-γ, and espD-γ and the four plasmid-borne factors (ehxA, katP, espP, and etpD). These isolates possessed vtx1 and/or vtx2. Sorbitol-fermenting O157:H7 strain 493/89 was negative for two of the plasmid-borne factors, katP and espP. Different combinations of virulence factors were found among the strains of the other VTEC and EPEC serotypes. For example, VTEC O26:H11 strain H19 was found to have the β subtype of the LEE genes and ehxA, katP, and espP on the large plasmid. VTEC O91:H21 strain B2F1 was LEE negative and positive for the adhesin Saa. EPEC strain E2348/69 (O127:H6) had the LEE-related genes eae-α, tir-α, and espD-α but was negative for all other factors tested.

It was unknown beforehand whether any of the assays for the tir subtypes would react with strains with eae subtype δ, ε, or ζ and whether any assays for the espD subtypes would be positive for strains with eae subtype δ, ε, θ, or ζ. It was found that both the control strain positive for eae-ε and other reference strains with this eae variant were positive by the tir-β- and the espD-β-specific assays (Table 2). The strain with eae-δ was positive by the assays for the α variants of tir and espD, and the strain with eae-ζ was positive by the assay for tir-α but negative by the assays for all three espD variants. The strains with the θ variants of eae and tir were negative by the espD-specific assays.

Detection and isolation of VTEC from cattle feces by TaqMan PCR and colony hybridization.A method was developed for the detection and isolation of VTEC strains in cattle feces. The method was based on screening of enriched samples by a multiplex TaqMan PCR assay for vtx1 and vtx2 (Table 3) and isolation of VTEC from the positive samples by the use of grid membranes with 1,600 separate cells. vtx-positive colonies were identified by hybridization with vtx-specific probes (Fig. 1). The detection and isolation method was used with 40 fecal samples from 2- to 6-month-old calves from two dairy cattle herds. Screening by the TaqMan PCR showed that 35 (88%) of these samples were positive for vtx: 14 samples were positive for vtx1, 10 were positive for vtx2, and 11 were positive for both vtx1 and vtx2. Sixteen of the positive samples were selected for isolation of VTEC. Samples were selected to represent those with all three combinations of vtx subtypes, and in addition, samples with a strong reaction by the TaqMan PCR assay were selected. With the use of one dilution of enrichment culture filtered through an HGMF, vtx-positive colonies were found in 15 of the 16 samples after hybridization. In most cases, several colonies were positive on each HGMF. Four to five positive colonies were subcultured and tested by the vtx1- and vtx2-specific TaqMan assay. However, not all isolates were found to be vtx positive after a pure culture was obtained, indicating that a colony growing in one cell of the grid membrane in some cases consisted of several different strains. At least one confirmed VTEC isolate was obtained from 14 of the 15 hybridization-positive samples.

Characterization of VTEC isolates.The VTEC isolates obtained from fecal samples from calves were further characterized by using the panel of 22 factors, O serogrouping, and vtx subtyping. When more than one isolate from the same sample had the same O serogroup and the same vtx profile, only one of these isolates was included in the further analysis, and thus, a total of 19 isolates were fully characterized. Between one and three different O groups and vtx profiles could be characterized from each positive sample. VTEC isolates representing five different O groups and/or virulence profiles were isolated from farm A. Ten different profiles were found on farm B (Table 4).

View this table:
  • View inline
  • View popup
TABLE 4.

Results of characterization of strains isolated from calves ages 2 to 6 months

Nine of the 15 (60%) different VTEC strains had vtx1 only, 5 (33%) strains had one or more vtx2 genes, and 1 strain had both vtx1 and vtx2c. Eight of the strains (53%) possessed the LEE pathogenicity island (positive for two or three of the three LEE genes tested for), and four different eae subtypes were found. Eleven strains (73%) were likely to harbor the large virulence plasmid (one to three of the four genes tested for). One O113 strain had the saa gene (Table 4). The most common virulence profile among the isolates from calves in both herds was vtx1, eae-ζ, tir-α, ehxA, and espP. This profile was found for serogroup O84 and O98 isolates (Table 4). Similar profiles with variation in the plasmid factors only were found for an O8 isolate (espP) and a nontypeable isolate (ehxA, espP, and etpD). Three other eae subtypes were identified (eae-β, -γ, and -ε).

DISCUSSION

The increasing focus on VTEC infections, especially infections caused by VTEC isolates of serotypes other than O157:H7 and O157:H−, has emphasized the necessity of having reliable methods for the detection and isolation of all VTEC strains pathogenic for humans from patients as well as relevant reservoirs, e.g., foods and animal feces. As VTEC isolates usually constitute a minority of the E. coli flora in fecal samples of healthy animals and in food samples, the task is to detect and isolate this minority of isolates, which have no common phenotypic traits that can differentiate them from nonpathogenic E. coli strains. Therefore, we have developed a method that can be used to screen for vtx-positive samples by real-time PCR. Screening is performed with enrichment cultures and is therefore similar to many other published methods based on PCR. However, the advantage is the use of real-time PCR and detection by fluorescence probes, which produce a final result within 2 h. Furthermore, it is important to obtain a bacterial isolate to be able to further characterize the isolate and thereby assess the virulence potential of the organism. Most vtx-positive E. coli O157:H7 and O157:H− strains have predictable virulence profiles; however, this is not the case for VTEC strains of other serotypes isolated from animals or food. As knowledge of the virulence profiles and the virulence potentials of non-O157 isolates from nonhuman sources is limited, it is important to further characterize these isolates. Only a few efficient methods exist for the isolation of VTEC strains from among a large indigenous E. coli flora. In this case, picking a few random colonies for further characterization is usually not sufficient to obtain a reasonable VTEC isolation rate. We have chosen to use the principle of DNA hybridization on grid filters, which has previously been used for the isolation of VTEC strains from enrichment cultures of fecal samples (9, 47). We found that it was possible to isolate one VTEC colony among approximately 500 other coliform colonies, and this method was sufficient to obtain an isolate from the majority of the PCR-positive samples. The fecal samples used in this study were obtained from calves ages 2 to 6 months. The prevalence of vtx-positive animals among the 40 calves from two dairy cattle herds was high (88%). This age group has previously been identified to be the group with the highest prevalence of VTEC O157 excretion in Danish cattle herds (32). Studies from other countries have also found a higher prevalence of VTEC O157 in calves than in cows (17). However, the prevalence of non-O157 VTEC strains in calves was higher than that in cows in some studies (50) but not in others (4). In the Danish study, the prevalence of VTEC O157 strains was 8.6% among the 2- to 6-month-old calves; i.e., the prevalence of all VTEC isolates can be expected to be approximately 10 times higher than the prevalence of VTEC O157 in calves in this age group.

We have developed real-time PCR assays for the detection of a wide range of virulence factors relevant primarily for VTEC isolates, but also to some extent for attaching-and-effacing E. coli and EPEC. The panel of assays can be used for the detection of vtx genes, genes of the LEE region, and genes of the large virulence plasmid. This panel can easily be extended to include other subtypes of specific genes in, for example, the LEE region or new factors when these are identified or when particular genes need to be detected for specific purposes. Our main interest has been to detect the VTEC virulence factors most important at present, but also to detect variants of some of these factors, as it has been shown that there is a strong correlation between, e.g., the eae variant, the serotype, and the presence of other virulence factors (33, 45, 52). Although some of the variants of the LEE genes are found only or primarily in EPEC strains, primers and probes for these variants are included to make the most complete characterization system.

Primer and probe design for TaqMan PCR assays needs to be very specific; i.e., it is necessary to find a region of the target gene of, preferably, less than 200 bp from which the sequences for two primers and one probe can be chosen. The sequences of the primers and probe should perfectly match the relevant sequence of the gene that is sought. This makes it difficult to design general assays for all variants of vtx, tir, and espD. On the other hand, the high degrees of specificity of the primers and probes are an advantage when assays for different subtypes are designed and only minor sequence differences separate the subtypes. Multiplex assays can easily be performed, so that all variants of vtx1 and vtx2 can be detected in one multiplex assay; i.e., screening for vtx-positive samples can be done by the use of one well per sample. Furthermore, the panel of detection assays can be used in two steps when unknown isolates are characterized. First, the isolates are tested for vtx1, vtx2, and eae (the general assay detects all subtypes), and the five plasmid-borne genes. Detection of these eight factors can be performed in four reaction wells. Then, eae-positive isolates are tested for the subtype of eae and the presence of variants of the other LEE genes (14 genes are detected in seven wells). In this study, we found that all isolates with a specific eae subtype had the same combination of tir and espD subtypes. If future characterization of a large number of LEE-positive isolates confirms this relationship between eae subtype and the subtypes of the other LEE-related genes, it might be sufficient to determine only the eae subtype.

For each of the 22 PCR assays, the expected results were obtained for the positive and negative control strains. Furthermore, a panel of 20 well-described strains was characterized by the use of all PCR assays to further validate the assays with a wider range of strains. The virulence profiles of these strains or other strains with the same O:H-serotype are partly known from the literature, except that the subtypes of the LEE genes have not always been described previously, and in most cases, only the eae subtype has been determined. In this study, information on the subtypes of two other LEE genes is added. All sorbitol-nonfermenting E. coli O157:H7 and O157:H− strains were shown to have the same profile, i.e., the γ variant of the LEE genes and the four plasmid-borne factors, which are found in the well-described strain E. coli EDL933 (7, 33). Sorbitol-fermenting O157:H− strain 493/89 was negative for two of the plasmid-borne factors, katP and espP, as has been shown to be characteristic of sorbitol-fermenting VTEC O157 strains (21). Another well-described strain, E. coli H19 O26:H11, was also found to have the expected profile, i.e., vtx1, three of the plasmid-borne factors (ehxA, katP, and espP; it was negative for etpD) (41), and the β variant of eae, and tir, and espD, as found in other strains of serotype O26:H11 (1, 8, 16). As expected from the literature, the VTEC O111:H− strains had three of the plasmid-borne genes (41) and the θ subtype of eae and tir. The presence of eae-θ in O111:H8 and O111:H− strains is in accordance with the findings of Oswald et al. (33), but with the renaming made by Tarr and Whittam (46); i.e., γ2 is θ. As expected, the human and rabbit EPEC strains had LEE-α and LEE-β, respectively, but were negative for vtx and pO157 genes.

It has previously been shown that specific genetic variants of the intimin gene are highly related to evolutionary lineages and, thereby, serotypes (1, 33). This has also been shown, but to a more limited extent, for the whole LEE region (38). We found a good concordance between the LEE subtypes, as all strains possessing eae-α, eae-β, or eae-γ also had the corresponding α, β, or γ subtypes of tir and espD. Furthermore, eae-θ strains were positive for tir-θ. Strains with eae-θ or eae-ζ were negative by the three assays specific for espD. However, it is most likely that these strains possess a variant of the espD gene that is not covered by our three PCR assays. This is substantiated by the fact that large variations in espD exist for the few espD genes that have been sequenced from different E. coli lineages; e.g., there was only 20% identity between espD from EPEC strain E2348/69 and espD from VTEC strain EDL933 (38). A heterologous relationship was found for three eae subtypes eae-δ, -ε, and -ζ. No tir or espD genes have yet been sequenced from strains with these eae subtypes. The sequences of the probes and primers for the subtype-specific PCR assays were in the extracellular C-terminal region of intimin, as large variations between intimin subtypes exist in this region. This is also the Tir-binding region of intimin; however, it has recently been shown that only a few amino acids are likely to be critical for Tir binding, and these residues are conserved among the different intimin types (26). Also, the intimin-binding area of Tir, the central portion of Tir, is conserved (23); and likewise, it has been predicted that only a few conserved residues are critical for binding (26). Our primers and probes for Tir are placed in the variable regions outside the central intimin-binding area. We found that all strains with eae-ε were positive for tir-β and espD-β. Tarr and Whittam (46) found that intimin-ε (represented by VTEC O103:H2 strain PMK5) was closely related to intimin-β when the periplasmic domain and the central domain of the protein sequence were analyzed, but for the extracellular domain, intimin-ε and intimin-β were only distally related. The single eae-δ strain in our study was positive for tir-α and espD-α. According to the phylogenetic trees created for the periplasmic and central domains of intimin subtypes, intimin-δ (exemplified by dog EPEC strain 4221) was closely related to intimin-α. Again, this relationship was not found for the extracellular domains (33). None of the reference strains had eae-ζ, but all isolates with this subtype obtained from cattle had tir-α and were negative by the three espD-specific assays. The former is in accordance with the findings of Tarr and Whittam (46), who found that tir from an O111:H9 strain (eae-ζ) was most closely related to the tir sequences of LEE-α strains. However, the tir sequence was not published or submitted to GenBank.

A large diversity of VTEC strains was isolated from calves on two cattle farms. VTEC strains were isolated from 16 calves, and the isolates were characterized by the 22-assay panel. At least 15 distinct strains were present, and it can be expected that even more different VTEC isolates would be obtained if more animals and more colonies were selected from these farms. All O serogroups represented by these isolates have previously been isolated from cattle, and furthermore, most of them have been associated with human disease (www.sciencenet.com.au/vtectableu.htm ). Most strains had either the vtx1 gene (60%) or the vtx2 gene (33%). The vtx distribution in this limited material is similar to the findings of a study with 361 non-O157 isolates from beef carcasses in the United States (2). Strains from human patients with VTEC infections more often possess vtx2 alone or together with vtx1. This is especially the case for VTEC strains associated with HUS (15). More than half of the strains (53%) possessed the LEE pathogenicity island. This is greater than the proportion of non-O157 VTEC strains with the eae gene found in cattle in many other studies, e.g., in Scotland, the United States, and Spain (17, 12, and 9%, respectively) (2, 4, 20). However, a much higher prevalence of eae (70%) was found among VTEC isolates from Germany and Belgium (49). A high prevalence of eae is usually found among isolates from human clinical cases, e.g., 70% among non-O157 isolates from Finland (10). All eae-positive strains in this study also harbored the large virulence plasmid (the strains were positive for one to three of the plasmid-borne genes tested for); in addition, a few other strains were also positive for some of the plasmid-borne factors (in total, 73%). An LEE-negative O113 strain had the adhesin Saa. O113 was among the serogroups in which Saa was originally identified (35). The strain isolated from a calf in this study had the same virulence profile as an O113 isolate obtained from another Danish cattle farm 1 year earlier (isolate DVI-450; Table 2). As Saa has just recently been described, the prevalence of saa among VTEC strains isolated from cattle is unknown. The most common virulence profile among isolates from both herds was vtx1, eae-ζ, tir-α, ehxA, and espP. This profile was found for strains of serotypes O84 and O98. Five of the eight LEE-positive strains characterized from these two farms had the eae-ζ subtype.

We have shown that the 22 real-time PCR assays described here are useful tools for determination of the virulence profiles of VTEC isolates and, to some degree, EPEC isolates as well. Together with the improved method for the detection and isolation of VTEC isolates from fecal samples, it is possible to isolate and characterize VTEC isolates from possible sources of human infections and compare the virulence profiles of those isolates to the virulence profiles of isolates from human infections. This comparison is important for assessing the sources of human VTEC infections. It is well known that ruminants often harbor VTEC isolates, but knowledge of the virulence potentials of these isolates is limited. Some knowledge of the virulence profiles of strains pathogenic for humans already exists; however, the subtypes of LEE genes are generally described only for the most common serotypes, and in most cases only the eae subtype has then been determined. In this study, information on the subtypes of two other LEE genes is added. We generally found concordance between the LEE subtypes, as all strains with four of the seven eae subtypes had the corresponding subtype of tir and espD, except that eae-θ strains were negative for espD. A heterologous relationship was found for three eae subtypes, eae-δ, -ε, and -ζ. However, as no tir or espD genes have yet been sequenced for strains with these eae subtypes, the variation outside the target region for our probes and primers is unknown. It is noteworthy that for a specific eae subtype, the same subtypes of the two other LEE genes were consistently found in all isolates obtained from multiple sources. In general, the O serogroups and virulence profiles of the majority of the cattle isolates obtained in this study indicate that these are likely pathogenic for humans, as these O groups and virulence profiles are also found among human clinical isolates.

ACKNOWLEDGMENTS

This work was supported by a grant (grant FØSI-01) from the Directorate for Food, Fisheries and Agri Business of the Danish Ministry of Food, Agriculture and Fisheries.

We thank Mette Sørensen and Henning V. Rasmussen for excellent technical assistance.

FOOTNOTES

    • Received 3 March 2003.
    • Returned for modification 16 March 2003.
    • Accepted 26 April 2003.
  • Copyright © 2003 American Society for Microbiology

REFERENCES

  1. 1.↵
    Adu-Bobie, J., G. Frankel, C. Bain, A. G. Goncalves, L. R. Trabulsi, G. Douce, S. Knutton, and G. Dougan. 1998. Detection of intimins alpha, beta, gamma, and delta, four intimin derivatives expressed by attaching and effacing microbial pathogens. J. Clin. Microbiol.36:662-668.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Arthur, T. M., G. A. Barkocy-Gallagher, M. Rivera-Betancourt, and M. Koohmaraie. 2002. Prevalence and characterization of non-O157 Shiga toxin-producing Escherichia coli on carcasses in commercial beef cattle processing plants. Appl. Environ. Microbiol.68:4847-4852.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Bastian, S. N., I. Carle, and F. Grimont. 1998. Comparison of 14 PCR systems for the detection and subtyping of stx genes in Shiga-toxin-producing Escherichia coli. Res. Microbiol.149:457-472.
    OpenUrlPubMed
  4. 4.↵
    Blanco, M., J. E. Blanco, J. Blanco, A. Mora, C. Prado, M. P. Alonso, M. Mourino, C. Madrid, C. Balsalobre, and A. Juarez. 1997. Distribution and characterization of faecal verotoxin-producing Escherichia coli (VTEC) isolated from healthy cattle. Vet. Microbiol.54:309-319.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Brunder, W., H. Schmidt, and H. Karch. 1996. KatP, a novel catalase-peroxidase encoded by the large plasmid of enterohaemorrhagic Escherichia coli O157:H7. Microbiology142(Pt 11):3305-3315.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    Brunder, W., H. Schmidt, and H. Karch. 1997. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol. Microbiol.24:767-778.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Burland, V., Y. Shao, N. T. Perna, G. Plunkett, H. J. Sofia, and F. R. Blattner. 1998. The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli O157:H7. Nucleic Acids Res.26:4196-4204.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    China, B., F. Goffaux, V. Pirson, and J. Mainil. 1999. Comparison of eae, tir, espA and espB genes of bovine and human attaching and effacing Escherichia coli by multiplex polymerase chain reaction. FEMS Microbiol. Lett.178:177-182.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    Cobbold, R., and P. Desmarchelier. 2000. A longitudinal study of Shiga-toxigenic Escherichia coli (STEC) prevalence in three Australian diary herds. Vet. Microbiol.71:125-137.
    OpenUrlCrossRefPubMed
  10. 10.↵
    Eklund, M., F. Scheutz, and A. Siitonen. 2001. Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: serotypes, virulence characteristics, and molecular profiles of strains of the same serotype. J. Clin. Microbiol.39:2829-2834.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Elliott, S. J., L. A. Wainwright, T. K. McDaniel, K. G. Jarvis, Y. K. Deng, L. C. Lai, B. P. McNamara, M. S. Donnenberg, and J. B. Kaper. 1998. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol. Microbiol.28:1-4.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    Fagan, P. K., M. A. Hornitzky, K. A. Bettelheim, and S. P. Djordjevic. 1999. Detection of Shiga-like toxin (stx1 and stx2), intimin (eaeA), and enterohemorrhagic Escherichia coli (EHEC) hemolysin (EHEC hlyA) genes in animal feces by multiplex PCR. Appl. Environ. Microbiol.65:868-872.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Frydendahl, K. 2002. Prevalence of serogroups and virulence genes in Escherichia coli associated with postweaning diarrhoea and edema disease in pigs and a comparison of diagnostic approaches. Vet. Microbiol.85:169-182.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Frydendahl, K., H. Imberechts, and S. Lehmann. 2001. Automated 5′ nuclease assay for detection of virulence factors in porcine Escherichia coli. Mol. Cell. Probes15:151-160.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    Gerber, A., H. Karch, F. Allerberger, H. M. Verweyen, and L. B. Zimmerhackl. 2002. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997- 2000, in Germany and Austria: a prospective study. J. Infect. Dis.186:493-500.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    Goffaux, F., B. China, and J. Mainil. 2001. Organisation and in vitro expression of esp genes of the LEE (locus of enterocyte effacement) of bovine enteropathogenic and enterohemorrhagic Escherichia coli. Vet. Microbiol.83:275-286.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    Heuvelink, A. E., F. L. van den Biggelaar, J. Zwartkruis-Nahuis, R. G. Herbes, R. Huyben, N. Nagelkerke, W. J. Melchers, L. A. Monnens, and E. De Boer. 1998. Occurrence of verocytotoxin-producing Escherichia coli O157 on Dutch dairy farms. J. Clin. Microbiol.36:3480-3487.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    Holland, P. M., R. D. Abramson, R. Watson, and D. H. Gelfand. 1991. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA88:7276-7280.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    Hoorfar, J., P. Ahrens, and P. Radstrom. 2000. Automated 5′ nuclease PCR assay for identification of Salmonella enterica. J. Clin. Microbiol.38:3429-3435.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    Jenkins, C., M. C. Pearce, H. Chart, T. Cheasty, G. A. Willshaw, G. J. Gunn, G. Dougan, H. R. Smith, B. A. Synge, and G. Frankel. 2002. An eight-month study of a population of verocytotoxigenic Escherichia coli (VTEC) in a Scottish cattle herd. J. Appl. Microbiol.93:944-953.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    Karch, H., and M. Bielaszewska. 2001. Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H(−) strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis. J. Clin. Microbiol.39:2043-2049.
    OpenUrlFREE Full Text
  22. 22.↵
    Karch, H., and T. Meyer. 1989. Single primer pair for amplifying segments of distinct Shiga-like-toxin genes by polymerase chain reaction. J. Clin. Microbiol.27:2751-2757.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    Kenny, B. 1999. Phosphorylation of tyrosine 474 of the enteropathogenic Escherichia coli (EPEC) Tir receptor molecule is essential for actin nucleating activity and is preceded by additional host modifications. Mol. Microbiol.31:1229-1241.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    Lee, L. G., C. R. Connell, and W. Bloch. 1993. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res.21:3761-3766.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    Lin, Z., H. Kurazono, S. Yamasaki, and Y. Takeda. 1993. Detection of various variant verotoxin genes in Escherichia coli by polymerase chain reaction. Microbiol. Immunol.37:543-548.
    OpenUrlCrossRefPubMed
  26. 26.↵
    Liu, H., P. Radhakrishnan, L. Magoun, M. Prabu, K. G. Campellone, P. Savage, F. He, C. A. Schiffer, and J. M. Leong. 2002. Point mutants of EHEC intimin that diminish Tir recognition and actin pedestal formation highlight a putative Tir binding pocket. Mol. Microbiol.45:1557-1573.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    Lyon, W. J. 2001. TaqMan PCR for detection of Vibrio cholerae O1, O139, non-O1, and non-O139 in pure cultures, raw oysters, and synthetic seawater. Appl. Environ. Microbiol.67:4685-4693.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    Makino, K., K. Ishii, T. Yasunaga, M. Hattori, K. Yokoyama, C. H. Yutsudo, Y. Kubota, Y. Yamaichi, T. Iida, K. Yamamoto, T. Honda, C. G. Han, E. Ohtsubo, M. Kasamatsu, T. Hayashi, S. Kuhara, and H. Shinagawa. 1998. Complete nucleotide sequences of 93-kb and 3.3-kb plasmids of an enterohemorrhagic Escherichia coli O157:H7 derived from Sakai outbreak. DNA Res.5:1-9.
    OpenUrlCrossRefPubMed
  29. 29.↵
    McDaniel, T. K., K. G. Jarvis, M. S. Donnenberg, and J. B. Kaper. 1995. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. USA92:1664-1668.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    Melton-Celsa, A. R., and A. D. O'Brien. 1998. Structure, biology, and relative toxicity of Shiga toxin family members for cells and animals, p. 121-128. In J. B. Kaper and A. D. O'Briene (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. ASM Press, Washington, D.C.
  31. 31.↵
    Nielsen, E. M., and F. Scheutz. 2002. Characterisation of Escherichia coli O157 isolates from Danish cattle and human patients by genotyping and presence and variants of virulence genes. Vet. Microbiol.88:259-273.
    OpenUrlCrossRefPubMed
  32. 32.↵
    Nielsen, E. M., C. Tegtmeier, H. J. Andersen, C. Gronbaek, and J. S. Andersen. 2002. Influence of age, sex and herd characteristics on the occurrence of verocytotoxin-producing Escherichia coli O157 in Danish dairy farms. Vet. Microbiol.88:245-257.
    OpenUrlCrossRefPubMed
  33. 33.↵
    Oswald, E., H. Schmidt, S. Morabito, H. Karch, O. Marchès, and A. Caprioli. 2000. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect. Immun.68:64-71.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    Paton, A. W., and J. C. Paton. 1999. Direct detection of Shiga toxigenic Escherichia coli strains belonging to serogroups O111, O157, and O113 by multiplex PCR. J. Clin. Microbiol.37:3362-3365.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    Paton, A. W., P. Srimanote, M. C. Woodrow, and J. C. Paton. 2001. Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. Infect. Immun.69:6999-7009.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    Paton, A. W., M. C. Woodrow, R. M. Doyle, J. A. Lanser, and J. C. Paton. 1999. Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of hemolytic-uremic syndrome. J. Clin. Microbiol.37:3357-3361.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    Paton, A. W., P. A. Manning, M. C. Woodrow, and J. C. Paton. 1998. Translocated intimin receptors (Tir) of Shiga-toxigenic Escherichia coli isolates belonging to serogroups O26, O111, and O157 react with sera from patients with hemolytic-uremic syndrome and exhibit marked sequence heterogeneity. Infect. Immun.66:5580-5586.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    Perna, N. T., G. F. Mayhew, G. Posfai, S. Elliott, M. S. Donnenberg, J. B. Kaper, and F. R. Blattner. 1998. Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7. Infect. Immun.66:3810-3817.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    Phillips, A. D., S. Navabpour, S. Hicks, G. Dougan, T. Wallis, and G. Frankel. 2000. Enterohaemorrhagic Escherichia coli O157:H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine. Gut47:377-381.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    Reischl, U., M. T. Youssef, J. Kilwinski, N. Lehn, W. L. Zhang, H. Karch, and N. A. Strockbine. 2002. Real-time fluorescence PCR assays for detection and characterization of Shiga toxin, intimin, and enterohemolysin genes from Shiga toxin-producing Escherichia coli. J. Clin. Microbiol.40:2555-2565.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    Schmidt, H., C. Geitz, P. I. Tarr, M. Frosch, and H. Karch. 1999. Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. J. Infect. Dis.179:115-123.
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    Schmidt, H., B. Henkel, and H. Karch. 1997. A gene cluster closely related to type II secretion pathway operons of gram-negative bacteria is located on the large plasmid of enterohemorrhagic Escherichia coli O157 strains. FEMS Microbiol. Lett.148:265-272.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    Sharma, V. K. 2002. Detection and quantitation of enterohemorrhagic Escherichia coli O157, O111, and O26 in beef and bovine feces by real-time polymerase chain reaction. J. Food Prot.65:1371-1380.
    OpenUrlPubMed
  44. 44.↵
    Szabo, R. A., E. C. D. Todd, and A. Jean. 1986. Method to isolate Escherichia coli O157 from food. J. Food Prot.49:768-772.
    OpenUrl
  45. 45.↵
    Tarr, C. L., T. M. Large, C. L. Moeller, D. W. Lacher, P. I. Tarr, D. W. Acheson, and T. S. Whittam. 2002. Molecular characterization of a serotype O121:H19 clone, a distinct Shiga toxin-producing clone of pathogenic Escherichia coli. Infect. Immun.70:6853-6859.
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    Tarr, C. L., and T. S. Whittam. 2002. Molecular evolution of the intimin gene in O111 clones of pathogenic Escherichia coli. J. Bacteriol.184:479-487.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    Todd, E. C., R. A. Szabo, J. M. MacKenzie, A. Martin, K. Rahn, C. Gyles, A. Gao, D. Alves, and A. J. Yee. 1999. Application of a DNA hybridization-hydrophobic-grid membrane filter method for detection and isolation of verotoxigenic Escherichia coli. Appl. Environ. Microbiol.65:4775-4780.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    Tozzi, A. E., S. Gorietti, and A. Caprioli. 2001. Epidemiology of human infections by Escherichia coli O157 and other verocytotoxin-producing E. coli, p. 161-180. In G. Duffy, P. Garvey, and D. A. McDowell (ed.), Verocytotoxigenic E. coli. Food & Nutrition Press, Inc., Trumbull, Conn.
  49. 49.↵
    Wieler, L. H., E. Vieler, C. Erpenstein, T. Schlapp, H. Steinruck, R. Bauerfeind, A. Byomi, and G. Baljer. 1996. Shiga toxin-producing Escherichia coli strains from bovines: association of adhesion with carriage of eae and other genes. J. Clin. Microbiol.34:2980-2984.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    Wilson, J. B., S. A. McEwen, R. C. Clarke, K. E. Leslie, R. A. Wilson, D. Waltner-Toews, and C. L. Gyles. 1992. Distribution and characteristics of verocytotoxigenic Escherichia coli isolated from Ontario dairy cattle. Epidemiol. Infect.108:423-439.
    OpenUrlCrossRefPubMed
  51. 51.↵
    World Health Organization. 1998. Zoonotic non-O157 Shiga toxin-producing Escherichia coli (STEC). Report of a WHO scientific working group meeting, p. 1-35. Department of Communicable Disease Surveillance and Response, World Health Organization, Geneva, Switzerland.
  52. 52.↵
    Zhang, W. L., B. Kohler, E. Oswald, L. Beutin, H. Karch, S. Morabito, A. Caprioli, S. Suerbaum, and H. Schmidt. 2002. Genetic diversity of intimin genes of attaching and effacing Escherichia coli strains. J. Clin. Microbiol.40:4486-4492.
    OpenUrlAbstract/FREE Full Text
  53. 53.↵
    Zhu, C., T. S. Agin, S. J. Elliott, L. A. Johnson, T. E. Thate, J. B. Kaper, and E. C. Boedeker. 2001. Complete nucleotide sequence and analysis of the locus of enterocyte effacement from rabbit diarrheagenic Escherichia coli RDEC-1. Infect. Immun.69:2107-2115.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Detection and Characterization of Verocytotoxin-Producing Escherichia coli by Automated 5′ Nuclease PCR Assay
Eva Møller Nielsen, Marianne Thorup Andersen
Journal of Clinical Microbiology Jul 2003, 41 (7) 2884-2893; DOI: 10.1128/JCM.41.7.2884-2893.2003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Detection and Characterization of Verocytotoxin-Producing Escherichia coli by Automated 5′ Nuclease PCR Assay
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Detection and Characterization of Verocytotoxin-Producing Escherichia coli by Automated 5′ Nuclease PCR Assay
Eva Møller Nielsen, Marianne Thorup Andersen
Journal of Clinical Microbiology Jul 2003, 41 (7) 2884-2893; DOI: 10.1128/JCM.41.7.2884-2893.2003
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Cattle Diseases
Escherichia coli
Feces
polymerase chain reaction
Shiga Toxin 1
Shiga toxins

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X